To include your compound in the COVID-19 Resource Center, submit it here.

Studies show Gilead drugs reduce HIV risk

Two studies published on Wednesday showed that two HIV drugs from Gilead Sciences Inc. (NASDAQ:GILD) significantly reduced the incidence of HIV infection when used in a prophylaxis setting. Gilead was up

Read the full 310 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE